← Back to Search

Financial Incentives + NRT for Smoking Cessation

N/A
Recruiting
Research Sponsored by University of Vermont Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass)
Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and >5 cigarette/day on average over the past 3 months)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test if financial incentives & medications help patients hospitalized for heart disease quit smoking. It could lead to better ways to get people to quit & improve health.

Who is the study for?
This trial is for adult smokers hospitalized due to a heart attack or heart surgery, living within 30 miles of UVMMC. Participants should be current cigarette users who have smoked more than 5 cigarettes per day in the past 3 months. Those with severe dementia, active cancer (except certain skin/prostate cancers), major exercise-limiting diseases, non-English speakers, or regular users of non-combusted tobacco are not eligible.Check my eligibility
What is being tested?
The study is testing if financial rewards and nicotine replacement therapy can help cardiac patients quit smoking after being hospitalized for a serious heart event. The goal is to see if these methods increase adherence to quitting smoking compared to usual care without incentives.See study design
What are the potential side effects?
Nicotine Replacement Therapy may cause mild side effects like nausea, headaches, skin irritation from patches, and sleep disturbances. Financial Incentives do not have direct medical side effects but could affect patient motivation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was hospitalized for a heart attack or heart surgery.
Select...
I currently smoke more than 5 cigarettes a day.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemical verification of smoking status
Secondary outcome measures
Cardiovascular Fitness
Other outcome measures
Anxiety assessed by GAD-7 Questionnaire
Depression assessed by PHQ-9 questionnaire
Health Care Contacts
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention: Financial incentives and nicotine replacement therapy interventionExperimental Treatment1 Intervention
an intervention where patients are assigned to financial incentives and NRT of their choice; use of CO monitor to assess abstinence
Group II: Control: Usual CareActive Control1 Intervention
will receive standard treatment which entails referral to Vermont Quit Network. This network offers a wide range of free cessation services, including NRT and web-based modules on preparing to quit and developing a plan

Find a Location

Who is running the clinical trial?

University of Vermont Medical CenterLead Sponsor
41 Previous Clinical Trials
25,775 Total Patients Enrolled

Media Library

Intervention: Financial incentives and nicotine replacement therapy intervention Clinical Trial Eligibility Overview. Trial Name: NCT05738408 — N/A
Smoking Cessation Research Study Groups: Intervention: Financial incentives and nicotine replacement therapy intervention, Control: Usual Care
Smoking Cessation Clinical Trial 2023: Intervention: Financial incentives and nicotine replacement therapy intervention Highlights & Side Effects. Trial Name: NCT05738408 — N/A
Intervention: Financial incentives and nicotine replacement therapy intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05738408 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers are engaging in this research project?

"Affirmative. Clinicaltrials.gov displays that this medical experiment, originally posted on August 12th 2022, is actively seeking participants. Fifty individuals need to be enlisted from a single trial centre."

Answered by AI

Are there any opportunities to enroll in this experiment currently?

"Affirmative. According to the information on clinicaltrials.gov, this research endeavour is presently seeking participants and was first posted on August 12th 2022. It has since received an update as recently as February 10th 2023 and 50 individuals are being recruited from a single site."

Answered by AI
~9 spots leftby Aug 2024